Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Keganliyan oral liquid for acute pharyngitis
ChiCTR2200057538Phase 4Recruiting
- Sponsor
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Start
- May 2021
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Kegang Liyan Oral Solution in acute pharyngitis (2 arms), sponsored by Guangdong Provincial Hospital of Traditional Chinese Medicine. Primary endpoint: Total disease response rate. Started May 2021; status: recruiting.
02
Drugs
Kegang Liyan Oral Solution
03
Conditions
acute pharyngitis
Beyond the preview
Go deeper on ChiCTR2200057538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057538.